HTML from...
URL: https://open.canada.ca/data/en/dataset/86f833f9-7b99-462a-bcce-0fc71cd2f829
Health Canada has notified Jennewein Biotechnologie, GmbH, that it has no objection to the use of 2'-fucosyllactose (2'-FL) derived from a genetically modified strain of E. coli BL21 (DE3), "the production strain" or "the strain", as an ingredient for infant formula. The Department conducted a comprehensive assessment of this oligosaccharide according to its Guidelines for the Safety Assessment of Novel Foods.
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | January 16, 2026 |
| Metadata last updated | January 16, 2026 |
| Created | January 16, 2026 |
| Format | HTML |
| License | License not specified |
| Datastore active | False |
| Has views | False |
| Id | dd8613bb-938f-4a4c-ac73-fc67de8cc655 |
| Package id | 6dddde0b-3a86-4a42-b460-317fd5498903 |
| Position | 0 |
| State | active |